|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma SV, Bell DW, Settleman J and Haber
DA: Epidermal growth factor receptor mutations in lung cancer. Nat
Rev Cancer. 7:169–181. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noone AM, Cronin KA, Altekruse SF,
Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence
and survival trends by subtype using data from the surveillance
epidemiology and end results program, 1992–2013. Cancer Epidemiol
Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X and Adjei AA: Lung cancer and
metastasis: New opportunities and challenges. Cancer Metastasis
Rev. 34:169–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koudelakova V, Kneblova M, Trojanec R,
Drabek J and Hajduch M: Non-small cell lung cancer-genetic
predictors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
157:125–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chalela R, Curull V, Enriquez C, Pijuan L,
Bellosillo B and Gea J: Lung adenocarcinoma: From molecular basis
to genome-guided therapy and immunotherapy. J Thorac Dis.
9:2142–2158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Damyanova V, Dimitrova-Dikanarova D,
Hadjidekova S, Savov A, Nesheva D, Rukova B, Vatev I and Toncheva
D: Genomic study in patients with idiopathic azoospermia and
oligoasthenoteratozoospermia. Akush Ginekol (Sofiia). 52:27–34.
2013.PubMed/NCBI
|
|
9
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak JK and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zarogoulidis P, Tsakiridis K, Karapantzou
C, Lampaki S, Kioumis I, Pitsiou G, Papaiwannou A,
Hohenforst-Schmidt W, Huang H, Kesisis G, et al: Use of proteins as
biomarkers and their role in carcinogenesis. J Cancer. 6:9–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He L, Zhang Y, Sun H, Jiang F, Yang H, Wu
H, Zhou T, Hu S, Kathera CS, Wang X, et al: Targeting DNA flap
endonuclease 1 to impede breast cancer progression. EBioMedicine.
14:32–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomas C, Ji Y, Lodhi N, Kotova E, Pinnola
AD, Golovine K, Makhov P, Pechenkina K, Kolenko V and Tulin AV:
Non-NAD-Like poly(ADP-Ribose) polymerase-1 inhibitors effectively
eliminate cancer in vivo. EBioMedicine. 13:90–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papaemmanuil E, Hosking FJ, Vijayakrishnan
J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E,
Irving JA, et al: Loci on 7p12.2, 10q21.2 and 14q11.2 are
associated with risk of childhood acute lymphoblastic leukemia. Nat
Genet. 41:1006–1010. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei CC, Nie FQ, Jiang LL, Chen QN, Chen
ZY, Chen X, Pan X, Liu ZL, Lu BB and Wang ZX: The pseudogene
DUXAP10 promotes an aggressive phenotype through binding with LSD1
and repressing LATS2 and RRAD in non small cell lung cancer.
Oncotarget. 8:5233–5246. 2017.PubMed/NCBI
|
|
18
|
Panagopoulos I, Brunetti M, Stoltenberg M,
Strandabø RAU, Staurseth J, Andersen K, Kostolomov I, Hveem TS,
Lorenz S, Nystad TA, et al: Novel GTF2I-PDGFRB and IKZF1-TYW1
fusions in pediatric leukemia with normal karyotype. Exp Hematol
Oncol. 8:122019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Studd JB, Yang M, Li Z, Vijayakrishnan J,
Lu Y, Yeoh AE, Paulsson K and Houlston RS: Genetic predisposition
to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a
CEBPE promoter polymorphism. Leukemia. 33:1–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li
M, Guan XY and Li Y: DHRS2 inhibits cell growth and motility in
esophageal squamous cell carcinoma. Oncogene. 37:1086–1094. 2018.
View Article : Google Scholar : PubMed/NCBI
|
